APW
GILD icon

Acima Private Wealth’s Gilead Sciences GILD Stock Holding History

Acima Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-231
Closed -$15K – 240
2020
Q3 		$15K Sell
231
-152
-40% -$10.5K 0.01% 188
2020
Q2 		$29K Hold
383
– – 0.02% 183
2020
Q1 		$29K Hold
383
– – 0.02% 184
2019
Q4 		$25K Hold
383
– – 0.02% 217
2019
Q3 		$24K Hold
383
– – 0.02% 209
2019
Q2 		$26K Hold
383
– – 0.02% 194
2019
Q1 		$25K Buy
383
+87
+29% +$5.78K 0.02% 193
2018
Q4 		$19K Buy
+296
New +$20.7K 0.02% 196

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Acima Private Wealth's GILD Position: Q4 2020 in Review

Acima Private Wealth sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 231 shares — an estimated $15K sold.

Acima Private Wealth first reported a position in GILD in Q4 2018 and held it in 8 quarters. The position peaked at $29K in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Acima Private Wealth reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Acima Private Wealth sold 231 Gilead Sciences shares in Q4 2020, an estimated $15K.
  • Acima Private Wealth first reported a position in Gilead Sciences in Q4 2018 and held it in 8 quarters.
  • Acima Private Wealth's Gilead Sciences position peaked at $29K in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Acima Private Wealth's 13F filing for Q4 2020, filed 14 May 2021.